These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32952113)

  • 1. Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma.
    Luo HB; Cao PB; Zhou GQ
    Yi Chuan; 2020 Aug; 42(8):775-787. PubMed ID: 32952113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma.
    Hao XY; Li AQ; Shi H; Guo TK; Shen YF; Deng Y; Wang LT; Wang T; Cai H
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33634306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
    Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
    Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
    Wang X; Xing Z; Xu H; Yang H; Xing T
    Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
    Li J; Chen N; Gong X
    Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.
    Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z
    BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
    Bedon L; Dal Bo M; Mossenta M; Busato D; Toffoli G; Polano M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
    Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
    DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients.
    Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB
    J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.